FORM 8-K

Company

GT Biopharma, Inc.

Filed

June 10, 2004

Period of Report

June 1, 2004

Accession Number

0001193125-04-101584

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →